Gastric Intestinal Metaplasia: An Intermediate Precancerous Lesion in the Cascade of Gastric Carcinogenesis.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of the College of Physicians and Surgeons--Pakistan : JCPSP

• Publication date

  2017-03-01

• Fields of study

  Medicine

• Identifiers
  PMID 28406776
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• SCHLAFEN 5 expression correlates with intestinal metaplasia that progresses to gastric cancer

  2016cited by this paper
• Microsatellite instability of gastric cancer and precancerous lesions.

  2015cited by this paper
• The Prevalence of Gastric Intestinal Metaplasia and Distribution of Helicobacter pylori Infection, Atrophy, Dysplasia, and Cancer in Its Subtypes

  2015cited by this paper
• Kyoto global consensus report on Helicobacter pylori gastritis

  2015cited by this paper
• Relationship of Helicobacter pylori eradication with gastric cancer and gastric mucosal histological changes: a 10‐year follow‐up study

  2014cited by this paper
• Helicobacter pylori associated chronic gastritis, clinical syndromes, precancerous lesions, and pathogenesis of gastric cancer development.

  2014cited by this paper
• Chronic gastritis in China: a national multi-center survey

  2014cited by this paper
• Correlation between Endoscopic and Histological Diagnoses of Gastric Intestinal Metaplasia

  2013cited by this paper
• Relationship between Endoscopic and Histologic Gastric Atrophy and Intestinal Metaplasia

  2013cited by this paper
• The Prevalence of Helicobacter pylori Infection Decreases with Older Age in Atrophic Gastritis

  2013cited by this paper
• Ten-year prospective follow-up of histological changes at five points on the gastric mucosa as recommended by the updated Sydney system after Helicobacter pylori eradication

  2012cited by this paper
• Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED)

  2012cited by this paper
• Expression of CDX2 and villin in gastric cardiac intestinal metaplasia and the relation with gastric cardiac carcinogenesis.

  2012cited by this paper
• Helicobacter pylori and the BMP pathway regulate CDX2 and SOX2 expression in gastric cells.

  2012cited by this paper
• Helicobacter pylori Eradication Improves Gastric Atrophy and Intestinal Metaplasia in Long-Term Observation

  2012cited by this paper
• Eradication of Helicobacter pylori infection improved gastric mucosal atrophy and prevented progression of intestinal metaplasia, especially in the elderly population: A long‐term prospective cohort study

  2010cited by this paper
• The Correlation of Endoscopic and Histological Diagnosis of Gastric Atrophy

  2010cited by this paper
• Risk factors in gastric cancer.

  2010cited by this paper
• Risk Factors Associated with Gastric Cancer in Patients with a Duodenal Ulcer

  2010cited by this paper
• Role of Interferon α (IFNα)-inducible Schlafen-5 in Regulation of Anchorage-independent Growth and Invasion of Malignant Melanoma Cells*

  2010cited by this paper
• Salt Intake and Risk of Gastric Intestinal Metaplasia: Systematic Review and Meta-Analysis

  2010cited by this paper
• Recent patterns in gastric cancer: A global overview

  2009cited by this paper
• Immunohistochemical expression of cell‐cycle proteins in gastric precancerous lesions

  2008cited by this paper
• Systematic review of the prevalence of gastric intestinal metaplasia and its area-level association with smoking.

  2008cited by this paper
• Key elements of the BMP/SMAD pathway co‐localize with CDX2 in intestinal metaplasia and regulate CDX2 expression in human gastric cell lines

  2008cited by this paper
• Helicobacter pylori Infection and Development of Gastric Cancer in Korea: Long-term Follow-up

  2008cited by this paper
• Two faces of p53: aging and tumor suppression

  2007cited by this paper
• The Detection, Surveillance and Treatment of Premalignant Gastric Lesions Related to Helicobacter pylori Infection

  2007cited by this paper
• CDX2 expression is progressively decreased in human gastric intestinal metaplasia, dysplasia and cancer

  2007cited by this paper
• [Histological changes of gastric atrophy and intestinal metaplasia after Helicobacter pylori eradication].

  2007cited by this paper
• ASGE guideline: the role of endoscopy in the surveillance of premalignant conditions of the upper GI tract.

  2006cited by this paper
• Type or extension of intestinal metaplasia and immature/atypical "indefinite-for-dysplasia" lesions as predictors of gastric neoplasia.

  2006cited by this paper
• Incidence and mortality of gastric cancer in China.

  2006cited by this paper
• Effects of bile reflux on gastric mucosal lesions in patients with dyspepsia or chronic gastritis.

  2005cited by this paper
• Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study

  2005cited by this paper
• Risk Factors Associated with the Development of Intestinal Metaplasia in First-Degree Relatives of Gastric Cancer Patients

  2005cited by this paper
• Long‐term follow‐up in atrophic body gastritis patients: atrophy and intestinal metaplasia are persistent lesions irrespective of Helicobacter pylori infection

  2005cited by this paper
• Helicobacter pylori Eradication and Gastric Preneoplastic Conditions

  2004cited by this paper
• Gastric intestinal metaplasia as detected by a monoclonal antibody is highly associated with gastric adenocarcinoma

  2003cited by this paper
• Helicobacter pylori eradication therapy improves atrophic gastritis and intestinal metaplasia: a 5‐year prospective study of patients with atrophic gastritis

  2002cited by this paper
• Effect of lifestyle, smoking, and diet on development of intestinal metaplasia in H. pylori-positive subjects

  2001cited by this paper
• Gastric intestinal metaplasia: subtypes and natural history.

  2001cited by this paper
• Microsatellite instability in gastric intestinal metaplasia in patients with and without gastric cancer.

  2000cited by this paper
• Association of Helicobacter pylori infection with gastric carcinoma: a meta-analysis

  1999cited by this paper
• Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2, MUC5AC, and MUC6) expression.

  1999cited by this paper
• Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer.

  1998cited by this paper
• Overexpression of p53 in different subtypes of intestinal metaplasia and gastric cancer.

  1998cited by this paper
• Gastritis in the Japanese stomach.

  1996cited by this paper
• Helicobacter pylori and gastric carcinogenesis.

  1996cited by this paper
• Helicobacter pylori and gastric carcinogenesis.

  1995cited by this paper
• Intestinal metaplasia types and the risk of gastric cancer: A cohort study in Slovenia

  1994cited by this paper
• Detection of an increased incidence of early gastric cancer in patients with intestinal metaplasia type III who are closely followed up.

  1991cited by this paper
• The production and characterization of monoclonal antibodies to a human colonic antigen associated with ulcerative colitis: cellular localization of the antigen by using the monoclonal antibody.

  1987cited by this paper
• The prognostic value of sulphomucin positive intestinal metaplasia in the development of gastric cancer

  1986cited by this paper
• Gastric cancer risk in chronic atrophic gastritis: Statistical calculations of cross‐sectional data

  1985cited by this paper
• Distribution of marker enzymes and mucin in intestinal metaplasia in human stomach and relation to complete and incomplete types of intestinal metaplasia to minute gastric carcinomas.

  1980cited by this paper

• Clinical analysis of the effect of helicobacter pylori infection on immune function in children with peptic ulcer

  2024cites this paper
• Helicobacter pylori and Epstein–Barr Virus Co-Infection in Gastric Disease: What Is the Correlation with p53 Mutation, Genes Methylation and Microsatellite Instability in a Cohort of Sicilian Population?

  2023cites this paper
• Atractylenolide III Attenuates Angiogenesis in Gastric Precancerous Lesions Through the Downregulation of Delta-Like Ligand 4

  2022cites this paper
• Features of the histostructure of the gastric mucosa in patients with atrophic gastritis combined with thyroid pathology

  2022cites this paper
• Advanced Imaging in Gastrointestinal Endoscopy: A Literature Review of the Current State of the Art

  2022cites this paper
• Differences in gastric microbiota and mucosal function between patients with chronic superficial gastritis and intestinal metaplasia

  2022cites this paper
• Epigallocatechin Gallate Protects against MNNG-Induced Precancerous Lesions of Gastric Carcinoma in Rats via PI3K/Akt/mTOR Pathway

  2021cites this paper
• Therapeutic effects of placenta derived-, umbilical cord derived-, and adipose tissue derived-mesenchymal stem cells in chronic Helicobacter pylori infection: comparison and novel mechanisms

  2021cites this paper
• Anti-gastric parietal cell antibodies for autoimmune gastritis screening in juvenile autoimmune thyroid disease

  2020cites this paper
• Dendrobium Officinale Polysaccharides Protect against MNNG-Induced PLGC in Rats via Activating the NRF2 and Antioxidant Enzymes HO-1 and NQO-1

  2019cites this paper
• Dendrobium officinale Polysaccharides Inhibit 1-Methyl-2-Nitro-1-Nitrosoguanidine Induced Precancerous Lesions of Gastric Cancer in Rats through Regulating Wnt/β-Catenin Pathway and Altering Serum Endogenous Metabolites

  2019cites this paper
• Gankyrin Drives Malignant Transformation of Gastric Cancer and Alleviates Oxidative Stress via mTORC1 Activation

  2018influential citation
• World Journal of Gastrointestinal Oncology

  year unknowncites this paper